FDA Approves Moxidectin
FDA Approves Moxidectin for the Treatment of River Blindness
MELBOURNE, GENEVA, and NEW YORK - June 13, 2018 -- Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and T
Amblyopia, Strabismus May Slow Test Performance in Children
THURSDAY, June 14, 2018 -- Children with certain eye conditions -- amblyopia or strabismus -- require more time to fill out multiple-choice answer forms, according to a study published online Ju
When DEA Cracked Down on Opioids, Abusers Moved to Black Market: Study
FRIDAY, June 15, 2018 -- Illegal opioid sales on the internet have surged in the wake of U.S. government crackdowns on prescriptions for the highly addictive painkillers, a new study
FDA Approves Fulphila
U.S. FDA Approves Fulphila (pegfilgrastim-jmdb), the First Biosimilar to Neulasta
HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India, June 4, 2018 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523,
Patients on Opioids OK With Lower Doses
FRIDAY, June 8, 2018 -- Even patients who have taken high doses of opioid painkillers for long periods of time arent unhappy with their care when their doctor lowers their dose, new research suggests.
The study
Noninvasive Blood Test Can Predict Gestational Age
FRIDAY, June 8, 2018 -- Noninvasive blood tests can predict gestational age and can identify women at risk for preterm delivery using cell-free RNA, according to a study published in the June 8 issue of